Physician profile
Christopher P Hayner
NPI 1710930748
$2,220.21
in general payments reported to CMS, 2019-2025
8 companies · $607 in 2025
The $607 reported for 2025 was more than what 92% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.47 · 2020: $90.10 · 2021: $665 · 2022: $349 · 2023: $124 · 2024: $304 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $549 · Education: $350 · Food and Beverage: $97.82 · Travel and Lodging: $37.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $548.98 |
| Education | $350.00 |
| Food and Beverage | $97.82 |
| Travel and Lodging | $37.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $709.03 | 2020-2025 | Invisalign |
| Ultradent Products INC | $613.93 | 2021-2023 | Opalescence |
| A-Dec, INC. | $558.57 | 2022-2025 | |
| Patterson Companies, INC. | $119.21 | 2022-2025 | |
| Straumann USA LLC | $94.00 | 2021 | |
| Biohorizons Implant Systems INC. | $81.47 | 2019 | |
| Benco Dental Supply Co. | $22.16 | 2021 | |
| Solventum Corporation | $21.84 | 2024 | 3m Scotchbond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hayner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.